Capital Adequacy (E) Task Force Working Agenda (Revised December 8, 2023)
2024 # |
Owner |
2024 Priority |
Expected Completion Date |
Working Agenda Item |
Source |
Comments |
Date Added to Agenda |
Ongoing Items – Life RBC |
|||||||
L1 |
Life RBC WG |
Ongoing |
Ongoing |
Make technical corrections to Life RBC instructions, blank and /or methods to provide for consistent treatment among asset types and among the various components of the RBC calculations for a single asset type. |
|||
L2 |
Life RBC WG |
1 |
2023 or later |
1. Monitor the impact of the changes to the variable annuities reserve framework and risk-based capital (RBC) calculation and determine if additional revisions need to be made. |
CADTF |
Being addressed by the Variable Annuities Capital and Reserve (E/A) Subgroup |
|
L3 |
Life RBC WG |
1 |
2023 or later |
Provide recommendations for the appropriate treatment of longevity risk transfers by the updated longevity factors and consider expanding the scope to include all payout annuities. |
New Jersey |
Being addressed by the Longevity (E/A) Subgroup |
|
L4 |
Life RBC WG |
1 |
2023 or later |
Monitor the economic scenario governance framework, review material economic scenario generator updates, key economic conditions, and metrics, support the implementation of an economic scenario generator for use in statutory reserve and capital calculations and develop and maintain acceptance criteria |
Being addressed by the Generator of Economic Scenarios (GOES) (E/A) Subgroup |
||
Carryover Items Currently being Addressed – Life RBC |
|||||||
Life RBC WG |
1 |
2023 or later |
Update the current C-3 Phase I or C-3 Phase II methodology to include indexed annuities with consideration of contingent deferred annuities as well |
AAA |
|||
L6 |
Life RBC WG |
1 |
2023 or later |
Review companies at action levels, including previous years, to determine what drivers of the events are and consider whether changes to the RBC statistics are warranted. |
|||
L7 |
Life RBC WG |
1 |
2023 or later |
Work with the Academy on creating guidance for the adopted C-2 mortality treatment for 2023 and next steps. |
|||
New Items – Life RBC |
|||||||
2024 # |
Owner |
2024 Priority |
Expected Completion Date |
Working Agenda Item |
Source |
Comments |
Date Added to Agenda |
Ongoing Items – RBC IR & E |
|||||||
Carryover Items Currently being Addressed – RBC IR &E |
|||||||
IR1 |
RBC IRE |
2 |
2023 or later |
Supplementary Investment Risks Interrogatories (SIRI) |
Referred from CADTF |
The Task Force received the referral on Oct. 27. This referral will be tabled until the bond factors have been adopted and the TF will conduct a holistic review all investment referrals. |
1/12/2022 11/19/2020 |
IR2 |
RBC IRE |
2 |
2023 or later |
NAIC Designation for Schedule D, Part 2 Section 2 - Common Stocks |
Referred from CADTF |
10/8/19 - Exposed for a 30-day Comment period ending 11/8/2019 |
1/12/2022 10/11/2018 |
IR3 |
RBC IRE |
2 |
2023 or later |
Structured Notes - defined as an investment that is structured to resemble a debt instrument, where the contractual amount of the instrument to be paid at maturity is at risk for other than the failure of the borrower to pay the contractual amount due. Structured notes reflect derivative instruments (i.e., put option or forward contract) that are wrapped by a debt structure. |
Referred from CADTF |
10/8/19 - Exposed for a 30-day Comment period ending 11/8/2019 |
1/12/2022 8/4/2019 |
IR4 |
RBC IRE |
2 |
2023 or later |
Comprehensive Fund Review for investments reported on Schedule D Pt 2 Sn2 |
Referred from CADTF |
Discussed during Spring Mtg. NAIC staff to do analysis. |
1/12/2022 11/16/2018 |
New Items – RBC IR & E |
|||||||
IR5 |
2023 or later |
Evaluate the appropriate RBC treatment of Asset-Backed Securities (ABS), including Collateralized Loan Obligations (CLO), collateralized fund obligations (CFOs), or other similar securities carrying similar types of tail risk (Complex Assets). |
Request from E Committee, SAPWG, VOSTF |
Per the request of E Committee comments were solicited asking if these types of assets should be considered a part of the RBC framework. |
1/12/2022 |
||
IR6 |
2023 or later |
Evaluate the appropriate RBC treatment of Residual Tranches. |
Request from E Committee, SAPWG, VOSTF |
Per the request of E Committee comments were solicited asking if these types of assets should be considered a part of the RBC framework. |
1/12/2022 |
||
IR7 |
2025 or later |
Phase 2 Bond analysis - evaluate and develop an approach to map other ABS to current bond factors following the established principles from Phase I where the collateral has an assigned RBC. This project will likely require an outside consultant and the timeline could exceed 2-3 years. |
Request from E Committee |
Per the request of E Committee comments were solicited requesting the need for outside review. |
1/12/2022 |
||
IR8 |
RBC IRE |
2023 or later |
Address the tail risk concerns no captured by reserves for privately structured securities. |
Referral from the Macroprudential (E) Working Group |
8/11/2022 |
2024 # |
Owner |
2024 Priority |
Expected Completion Date |
Working Agenda Item |
Source |
Comments |
Date Added to Agenda |
Ongoing Items – P&C RBC |
|||||||
Cat Risk SG |
1 |
Continue development of RBC formula revisions to include a risk charge based on catastrophe model output: |
|||||
Year-end 2024 or later |
a) Evaluate other catastrophe risks for possible inclusion in the charge |
Referral from the Climate and Resiliency Task Force. March 2021 |
12/2/23-Proposal 2023-15-CR (Convective Storm for Informational Purposes Only Structure) was exposed for a 60-day comment period at the Joint P/C RBC and Cat Risk SG meeting. |
4/26/2021 |
|||
P2 |
PCRBCWG |
1 |
Ongoing |
Review and analyze the P/C RBC charges that have not been reviewed since developed. |
3/23/2023 |
||
Carryover Items Currently being Addressed – P&C RBC |
|||||||
P&C RBC WG |
1 |
Year-end 2025 or later |
Evaluate a) the current growth risk methodology whether it is adequately reflects both operational risk and underwriting risk; b) the premium and reserve based growth risk factors either as a stand-alone task or in conjunction with the ongoing underwriting risk factor review with consideration of the operational risk component of excessive growth; c) whether the application of the growth factors to NET proxies adequately accounts for growth risk that is ceded to reinsures that do not trigger growth risk in their own right. |
Referral from Operational Risk Subgroup |
1) Sent a referral to the Academy on 6/14/18 conference call. |
1/25/2018 |
|
P4 |
P&C RBC WG |
1 |
2024 Summer Meeting or later |
Continue working with the Academy to review the methodology and revise the underwriting (Investment Income Adjustment, Loss Concentration, LOB UW risk) charges in the PRBC formula as appropriate. |
11/16/23 The Academy provided a presentation on their Underwriting Risk Report at the Joint PCRBC And Cat Risk SG meeting. |
6/10/2019 |
|
P5 |
P&C RBC WG |
1 |
2025 Summer Meeting or later |
Evaluate the Underwriting Risk Line 1 Factors in the P/C formula. |
7/30/2020 |
||
P6 |
Cat Risk SG |
1 |
2025 Spring Meeting |
Quantify the R5 Ex-cat Factors for wildfire peril (for informational purposes only) |
3/21/2023 |
||
P7 |
Cat Risk SG |
2 |
2025 Spring Meeting |
Evaluate the impact of flood peril to the insurance market |
3/21/2023 |
||
P8 |
PCRBCWG |
1 |
2024 Spring Meeting |
Adding pet insurance line in the RBC PR017, 018, 035 and RBC Schedule P, parts due to the adoption of the Annual Statement Blanks proposal 2023-01BWG. |
12/2/23 Proposal 2023-14-P (Pet Insurance) was exposed for a 60-day comment period at the Joint P/C RBC and Cat Risk SG meeting. |
7/27/2023 |
|
New Items – P&C RBC |
|||||||
Cat Risk SG |
1 |
2024 Summer Meeting |
Create a new disclosure to collect more information of insurers catastrophe reinsurance programs. |
Referral from Reinsurance (E) Task Force |
11/16/23 Received a referral and proposal from RTF. |
2/20/2024 |
|
P10 |
PCRBCWG |
1 |
2024 Summer Meeting |
Update PR019, Line 25 Annual Statement Source and the Statement Value to avoid double-counting on Stop-Loss premium. |
2/20/2024 |
||
P11 |
Cat Risk SG |
1 |
2024 Summer Meeting |
Create additional Rcat pages to collect commercial Cat modelers product information known as “Climate Conditioned Catalogs”, which would provide an estimate of climate change for hurricane and wildfire. |
From Solvency Workstream of the Climate & Resiliency (EX) Task Force |
1/29/24 Proposal 2023-17-CR was exposed for a 30-day public comment period at the Cat Risk SG Interim Meeting on Jan. 29. |
1/29/2024 |
P12 |
PCRBCWG |
1 |
2024 Spring Meeting |
Change the RBC Schedule P short-tail lines to vendor link, which will pull directly from the Annual Statement, Schedule P short-tail lines as the adopted blanks proposal 2023-16BWG modified the Schedule P short-tail lines to show 10 years of data beginning in 2024. |
2/21/24 Blanks Proposal 2023-16BWG was adopted at the BWG meeting |
2024 # |
Owner |
2024 Priority |
Expected Completion Date |
Working Agenda Item |
Source |
Comments |
Date Added to Agenda |
Ongoing Items – Health RBC |
|||||||
X1 |
Health RBC WG |
Yearly |
Yearly |
Evaluate the yield of the 6-month U.S. Treasury Bond as of Jan. 1 each year to determine if further modification to the Comprehensive Medical, Medicare Supplement and Dental and Vision underwriting risk factors is required. Any adjustments will be rounded up to the nearest 0.5%. |
HRBCWG |
Adopted 2022-16-CA (YE-2023) |
11/4/2021 |
X2 |
Health RBC WG |
3
|
Ongoing
|
Continue to monitor the Federal Health Care Law or any other development of federal level programs and actions (e.g., state reinsurance programs, association health plans, mandated benefits, and cross-border) for future changes that may have an impact on the Health RBC Formula. |
4/13/2010 CATF Call |
Adopted 2014-01H Discuss and monitor the development of federal level programs and the potential impact on the HRBC formula. |
1/11/2018 |
Carryover Items Currently being Addressed – Health RBC |
|||||||
X3 |
Health RBC WG |
2 |
Year-End 2025 RBC or Later |
Consider changes for stop-loss insurance or reinsurance. |
AAA Report at Dec. 2006 Meeting |
(Based on Academy report expected to be received at YE-2016) |
|
X4 |
Health RBC WG |
2 |
Year-end 2025 RBC or later |
Review the individual factors for each health care receivables line within the Credit Risk H3 component of the RBC formula. |
HRBC WG |
Adopted 2016-06-H |
|
X5 |
Health RBC WG |
1 |
Year-end 2025 RBC or later |
Work with the Academy to perform a comprehensive review of the H2 - Underwriting Risk component of the health RBC formula including the Managed Care Credit review (Item 18 above) Review the Managed Care Credit calculation in the health RBC formula - specifically Category 2a and 2b. Review Managed Care Credit across formulas. As part of the H2 - Underwriting Risk review, determine if other lines of business should include investment income and how investment income would be incorporated into the existing lines if there are changes to the structure. |
HRBCWG |
Review the Managed Care Category and the credit calculated, more specifically the credit calculated when moving from Category 0 & 1 to 2a and 2b. |
4/23/2021 12/3/2018 |
X6 |
Health RBC WG |
1 |
Year-end 2025 or later |
Review referral letter from the Operational Risk (E) Subgroup on the excessive growth charge and the development of an Ad Hoc group to charge. |
HRBCWG |
Review if changes are required to the Health RBC Formula |
4/7/2019 |
X7 |
Health RBC WG |
3 |
Year-End 2025 or later |
Discuss and determine the re-evaluation of the bond factors for the 20 designations. |
Referral from Investment RBC July/2020 |
Working Group will use two- and five-year time horizon factors in 2020 impact analysis. Proposal 2021-09-H - Adopted 5/25/21 by the WG |
9/11/2020 |
New Items – Health RBC |
|||||||
2024 # |
Owner |
2024 Priority |
Expected Completion Date |
Working Agenda Item |
Source |
Comments |
Date Added to Agenda |
Ongoing Items – Task Force |
|||||||
CA1 |
CADTF |
2 |
2023 |
Affiliated Investment Subsidiaries Referral |
Ad Hoc Group |
Structural and instructions changes will be exposed by each individual working group for comment in 2022 with an anticipated effective date of 2023. |
|
CA2 |
Ongoing |
All investment related items referred to the RBC Investment Risk & Evaluation (E) Working Group |
Proposal 2024-02-CA (Residual Structure PC & Health) was exposed for comment ending Mar. 2. |
1/12/2022 |
|||
CA3 |
CADTF |
3 |
Ongoing |
Receivable for Securities factor |
Consider evaluating the factor every 3 years. Factors will be exposed for comments in April 2024. |
||
CA4 |
CADTF |
1 |
2026 or later |
Established the Risk Evaluation Ad Hoc Group to:
|
7/26/23 – the Risk Evaluation Ad Hoc Group established 3 Ad Hoc Subgroup to focus on different issues: 1) RBC Purposes & Guidelines Ad Hoc Subgroup; 2) Asset Concentration Ad Hoc Subgroup; and 3) Geographic Concentration Ad Hoc Subgroup. |
03/23/2023 |
|
Carryover Items Currently being Addressed – Task Force |
|||||||
New Items –Task Force |
|||||||
CADTF |
2 |
2024 or later |
Evaluate if changes should be made in the RBC formula to reflect the split of the Annual Statement, Schedule D, Part 1 into two sections. |
Blanks WG and SAPWG |
12/2/23 – the TF agreed to send a referral to the RBCIREWG to continue reviewing this issue. |
12/2/2023 |
|
CA6 |
CADTF |
2 |
2024 or later |
Evaluate if changes should be made in the RBC formula to reflect the possible changes in the Annual Statement, Schedule BA proposal for non-bond debt securities. |
Blanks WG and SAPWG |
12/2/23 – the TF received a referral from SAPWG regarding the possible Annual Statement reporting for debt securities that do not qualify as bonds on Schedule BA. TF agreed to forward the referral along with the ACLI comment to the RBCIREWG. |
12/2/2023 |
CA7 |
CADTF |
2 |
2024 or later |
Evaluate if changes should be made in the RBC formula to reflect the possible changes in Schedule BA Collateral Loan reporting, including structural changes to RBC blanks and forecasting and changes of risk charges that commensurate with underlying collateral type. |
1/23/24 – the TF received a referral from SAPWG regarding collateral loan reporting changes |
1/23/2024 |
|
CA8 |
CADTF |
2 |
2024 or later |
Review the proposal from the ACLI to modify the treatment of repurchase agreements in the Life RBC formula to determine whether its possible application to P/C and Health formulas. |
Life RBC WG |
1/25/24 – the TF received a referral from LRBCWG. Proposal 2024-06-CA (Repurchase Agreements PC & Health( was exposed for comment ending Mar.2. |
1/25/2024 |
CA9 |
CADTF |
2 |
2024 or later |
Establish a long-term approach for the issue of the negative interest maintenance reserve (IMR). |
SAPWG |
12/2/23 – the TF agreed to forward the referral to LRBCWG. |
12/2/2023 |